PUBLISHER: QYResearch | PRODUCT CODE: 1484574
PUBLISHER: QYResearch | PRODUCT CODE: 1484574
This research report focuses on the Drug Treatment for Respiratory Disease Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
Table 1. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Asthma
Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other Diseases
Table 6. Global Drug Treatment for Respiratory Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drug Treatment for Respiratory Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Drug Treatment for Respiratory Disease Market Share by Region (2019-2024)
Table 10. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Drug Treatment for Respiratory Disease Market Share by Region (2025-2030)
Table 12. Drug Treatment for Respiratory Disease Market Trends
Table 13. Drug Treatment for Respiratory Disease Market Drivers
Table 14. Drug Treatment for Respiratory Disease Market Challenges
Table 15. Drug Treatment for Respiratory Disease Market Restraints
Table 16. Global Drug Treatment for Respiratory Disease Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Drug Treatment for Respiratory Disease Market Share by Players (2019-2024)
Table 18. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)
Table 19. Global Drug Treatment for Respiratory Disease Industry Ranking 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Drug Treatment for Respiratory Disease Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Drug Treatment for Respiratory Disease, Headquarters and Area Served
Table 22. Global Key Players of Drug Treatment for Respiratory Disease, Product and Application
Table 23. Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2019-2024)
Table 27. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2025-2030)
Table 29. Global Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2019-2024)
Table 31. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2025-2030)
Table 33. North America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Drug Treatment for Respiratory Disease Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
Table 65. GSK Company Details
Table 66. GSK Business Overview
Table 67. GSK Drug Treatment for Respiratory Disease Product
Table 68. GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 69. GSK Recent Development
Table 70. AstraZeneca Company Details
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca Drug Treatment for Respiratory Disease Product
Table 73. AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 74. AstraZeneca Recent Development
Table 75. Boehringer Ingelheim Company Details
Table 76. Boehringer Ingelheim Business Overview
Table 77. Boehringer Ingelheim Drug Treatment for Respiratory Disease Product
Table 78. Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 79. Boehringer Ingelheim Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Drug Treatment for Respiratory Disease Product
Table 83. Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Mylan Company Details
Table 86. Mylan Business Overview
Table 87. Mylan Drug Treatment for Respiratory Disease Product
Table 88. Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 89. Mylan Recent Development
Table 90. Vertex Pharmaceuticals Company Details
Table 91. Vertex Pharmaceuticals Business Overview
Table 92. Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Product
Table 93. Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 94. Vertex Pharmaceuticals Recent Development
Table 95. F. Hoffman La Roche Company Details
Table 96. F. Hoffman La Roche Business Overview
Table 97. F. Hoffman La Roche Drug Treatment for Respiratory Disease Product
Table 98. F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 99. F. Hoffman La Roche Recent Development
Table 100. Teva Pharmaceuticals Company Details
Table 101. Teva Pharmaceuticals Business Overview
Table 102. Teva Pharmaceuticals Drug Treatment for Respiratory Disease Product
Table 103. Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 104. Teva Pharmaceuticals Recent Development
Table 105. Cipla Company Details
Table 106. Cipla Business Overview
Table 107. Cipla Drug Treatment for Respiratory Disease Product
Table 108. Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 109. Cipla Recent Development
Table 110. Fibrogen Company Details
Table 111. Fibrogen Business Overview
Table 112. Fibrogen Drug Treatment for Respiratory Disease Product
Table 113. Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 114. Fibrogen Recent Development
Table 115. Liminal Biosciences Company Details
Table 116. Liminal Biosciences Business Overview
Table 117. Liminal Biosciences Drug Treatment for Respiratory Disease Product
Table 118. Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 119. Liminal Biosciences Recent Development
Table 120. PharmAkea Therapeutics Company Details
Table 121. PharmAkea Therapeutics Business Overview
Table 122. PharmAkea Therapeutics Drug Treatment for Respiratory Disease Product
Table 123. PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 124. PharmAkea Therapeutics Recent Development
Table 125. IQVIA Company Details
Table 126. IQVIA Business Overview
Table 127. IQVIA Drug Treatment for Respiratory Disease Product
Table 128. IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 129. IQVIA Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Figure 1. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Drug Treatment for Respiratory Disease Market Share by Type: 2023 VS 2030
Figure 3. Asthma Features
Figure 4. Chronic Obstructive Pulmonary Disease (COPD) Features
Figure 5. Lung Cancer Features
Figure 6. Other Diseases Features
Figure 7. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Drug Treatment for Respiratory Disease Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Drug Treatment for Respiratory Disease Report Years Considered
Figure 13. Global Drug Treatment for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Drug Treatment for Respiratory Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Drug Treatment for Respiratory Disease Market Share by Region: 2023 VS 2030
Figure 16. Global Drug Treatment for Respiratory Disease Market Share by Players in 2023
Figure 17. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Drug Treatment for Respiratory Disease Revenue in 2023
Figure 19. North America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
Figure 21. North America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
Figure 22. North America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)
Figure 23. United States Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
Figure 27. Europe Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
Figure 28. Europe Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)
Figure 29. Germany Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. China Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
Figure 37. China Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
Figure 38. Asia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Asia Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
Figure 40. Asia Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
Figure 41. Asia Drug Treatment for Respiratory Disease Market Share by Region (2019-2030)
Figure 42. Japan Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)
Figure 52. Brazil Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. GSK Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 59. AstraZeneca Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 61. Novartis Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 62. Mylan Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 63. Vertex Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 64. F. Hoffman La Roche Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 65. Teva Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 66. Cipla Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 67. Fibrogen Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 68. Liminal Biosciences Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 69. PharmAkea Therapeutics Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 70. IQVIA Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed